INmune Bio
INMB
#8707
Rank
ยฃ86.13 M
Marketcap
ยฃ3.88
Share price
2.31%
Change (1 day)
-43.84%
Change (1 year)

Revenue for INmune Bio (INMB)

Revenue in 2024 (TTM): ยฃ0.06 Million

According to INmune Bio's latest financial reports the company's current revenue (TTM ) is ยฃ0.06 Million. In 2023 the company made a revenue of ยฃ0.12 Million a decrease over the revenue in the year 2022 that were of ยฃ0.3 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for INmune Bio from 2018 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.06 M-43.84%
2023 ยฃ0.12 M-60.64%
2022 ยฃ0.3 M130.55%
2021 ยฃ0.13 M1574.37%
2020 ยฃ0 M
2019 N/A
2018 N/A